Correlation Between STAAR Surgical and GlucoTrack

Can any of the company-specific risk be diversified away by investing in both STAAR Surgical and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining STAAR Surgical and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between STAAR Surgical and GlucoTrack, you can compare the effects of market volatilities on STAAR Surgical and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in STAAR Surgical with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of STAAR Surgical and GlucoTrack.

Diversification Opportunities for STAAR Surgical and GlucoTrack

0.72

Correlation Coefficient

STAAR Surgical  GlucoTrack

Poor diversification

The 3 months correlation between STAAR and GlucoTrack is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding STAAR Surgical and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and STAAR Surgical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on STAAR Surgical are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of STAAR Surgical i.e., STAAR Surgical and GlucoTrack go up and down completely randomly.

Pair Corralation between STAAR Surgical and GlucoTrack

Given the investment horizon of 90 days STAAR Surgical is expected to generate 0.34 times more return on investment than GlucoTrack. However, STAAR Surgical is 2.98 times less risky than GlucoTrack. It trades about -0.08 of its potential returns per unit of risk. GlucoTrack is currently generating about -0.33 per unit of risk. If you would invest  2,408  in STAAR Surgical on December 29, 2024 and sell it today you would lose (629.00) from holding STAAR Surgical or give up 26.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

STAAR Surgical  vs.  GlucoTrack

STAAR Surgical

Risk-Adjusted Performance

Very Weak

Over the last 90 days STAAR Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

GlucoTrack

Risk-Adjusted Performance

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with STAAR Surgical and GlucoTrack

The main advantage of trading using opposite STAAR Surgical and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if STAAR Surgical position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.

The idea behind STAAR Surgical and GlucoTrack pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.